Watanabe, K.; Arozal, W.; Sari, F.R.; Arumugam, S.; Thandavarayan, R.A.; Suzuki, K.; Kodama, M.
The Role of Carvedilol in the Treatment of Dilated and Anthracyclines-Induced Cardiomyopathy. Pharmaceuticals 2011, 4, 770-781.
https://doi.org/10.3390/ph4050770
AMA Style
Watanabe K, Arozal W, Sari FR, Arumugam S, Thandavarayan RA, Suzuki K, Kodama M.
The Role of Carvedilol in the Treatment of Dilated and Anthracyclines-Induced Cardiomyopathy. Pharmaceuticals. 2011; 4(5):770-781.
https://doi.org/10.3390/ph4050770
Chicago/Turabian Style
Watanabe, Kenichi, Wawaimuli Arozal, Flori R. Sari, Somasundaram Arumugam, Rajarajan A. Thandavarayan, Kenji Suzuki, and Makoto Kodama.
2011. "The Role of Carvedilol in the Treatment of Dilated and Anthracyclines-Induced Cardiomyopathy" Pharmaceuticals 4, no. 5: 770-781.
https://doi.org/10.3390/ph4050770
APA Style
Watanabe, K., Arozal, W., Sari, F. R., Arumugam, S., Thandavarayan, R. A., Suzuki, K., & Kodama, M.
(2011). The Role of Carvedilol in the Treatment of Dilated and Anthracyclines-Induced Cardiomyopathy. Pharmaceuticals, 4(5), 770-781.
https://doi.org/10.3390/ph4050770